Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	94
Overall Study	STARTED	Low Dose SPN-810 (18 mg)	56
Overall Study	STARTED	High Dose SPN-810 (36 mg)	142
Overall Study	Intent-to-Treat	Placebo	92
Overall Study	Intent-to-Treat	Low Dose SPN-810 (18 mg)	55
Overall Study	Intent-to-Treat	High Dose SPN-810 (36 mg)	140
Overall Study	Modified Intent-to Treat	Placebo	90
Overall Study	Modified Intent-to Treat	Low Dose SPN-810 (18 mg)	53
Overall Study	Modified Intent-to Treat	High Dose SPN-810 (36 mg)	135
Overall Study	COMPLETED	Placebo	84
Overall Study	COMPLETED	Low Dose SPN-810 (18 mg)	45
Overall Study	COMPLETED	High Dose SPN-810 (36 mg)	113
Overall Study	NOT COMPLETED	Placebo	10
Overall Study	NOT COMPLETED	Low Dose SPN-810 (18 mg)	11
Overall Study	NOT COMPLETED	High Dose SPN-810 (36 mg)	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02618434/flow